INSMED Inc — Director's Dealing 2017

Sep 7, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2017-09-05

Reporting Person: SHAROKY MELVIN MD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-05	Common Stock	S	8466	$29.00	Disposed	267262	Direct
2017-09-05	Common Stock	S	12128	$28.69	Disposed	255134	Direct
2017-09-05	Common Stock	S	4406	$29.35	Disposed	250728	Direct
2017-09-06	Common Stock	S	8792	$26.07	Disposed	241936	Direct
2017-09-06	Common Stock	S	16208	$25.71	Disposed	225728	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.84 to $29.20, inclusive.

F3: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.56 to $28.82, inclusive.

F4: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.21 to $29.50, inclusive.

F5: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.89 to $26.40, inclusive.

F6: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.50 to $25.88, inclusive.

F7: The number of shares reflected here excludes 443 shares previously reported for which Dr. Sharoky does not have beneficial ownership.